Slp2-a controls renal epithelial cell size through regulation of Rap-ezrin signaling independently of Rab27

Journal of Cell Science

Volumn 127, Issue 3, 2014, Pages 557-570

  Yasuda, Takao ^a   Fukuda, Mitsunori ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Cell size; Ezrin; Polycystic kidney disease; Rap1GAP; Slp2 a

Indexed keywords

CELL SIZE; EZRIN; POLYCYSTIC KIDNEY DISEASE; RAP1GAP; SLP2-A;

ANIMALS; CELL MEMBRANE; CELL SIZE; CYTOSKELETAL PROTEINS; EPITHELIAL CELLS; KIDNEY; MEMBRANE PROTEINS; MICE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RAB GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84894065213     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.134056     Document Type: Article

References (56)

1. Arthur, W. T., Quilliam, L. A. and Cooper, J. A. (2004). Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors. J. Cell Biol. 167, 111-122.
2. Bergmann, C., Fliegauf, M., Brüchle, N. O., Frank, V., Olbrich, H., Kirschner, J., Schermer, B., Schmedding, I., Kispert, A., Kränzlin, B. et al. (2008). Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia. Am. J. Hum. Genet. 82, 959-970.
3. Bos, J. L., de Rooij, J. and Reedquist, K. A. (2001). Rap1 signalling: adhering to new models. Nat. Rev. Mol. Cell Biol. 2, 369-377.
4. Bretscher, A., Edwards, K. and Fehon, R. G. (2002). ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell Biol. 3, 586-599.
5. Canals, D., Jenkins, R. W., Roddy, P., Hernández-Corbacho, M. J., Obeid, L. M. and Hannun, Y. A. (2010). Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane. J. Biol. Chem. 285, 32476-32485.
6. Canals, D., Roddy, P. and Hannun, Y. A. (2012). Protein phosphatase 1a mediates ceramide-induced ERM protein dephosphorylation: a novel mechanism independent of phosphatidylinositol 4, 5-biphosphate (PIP2) and myosin/ERM phosphatase. J. Biol. Chem. 287, 10145-10155.
7. Catz, S. D., Johnson, J. L. and Babior, B. M. (2001). Characterization of the nucleotide-binding capacity and the ATPase activity of the PIP3-binding protein JFC1. Proc. Natl. Acad. Sci. USA 98, 11230-11235.
8. Charron, A. J., Nakamura, S., Bacallao, R. and Wandinger-Ness, A. (2000). Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells. J. Cell Biol. 149, 111-124.
9. Fukuda, M. (2002). The C2A domain of synaptotagmin-like protein 3 (Slp3) is an atypical calcium-dependent phospholipid-binding machine: comparison with the C2A domain of synaptotagmin I. Biochem. J. 366, 681-687.
10. Fukuda, M. (2006). Rab27 and its effectors in secretory granule exocytosis: a novel docking machinery composed of a Rab27?effector complex. Biochem. Soc. Trans. 34, 691-695.
11. Fukuda, M. and Kuroda, T. S. (2002). Slac2-c (synaptotagmin-like protein homologue lacking C2 domains-c), a novel linker protein that interacts with Rab27, myosin Va/VIIa, and actin. J. Biol. Chem. 277, 43096-43103.
12. Fukuda, M. and Mikoshiba, K. (2001). Synaptotagmin-like protein 1-3: a novel family of C-terminal-type tandem C2 proteins. Biochem. Biophys. Res. Commun. 281, 1226-1233.
13. Fukuda, M., Kanno, E. and Mikoshiba, K. (1999). Conserved N-terminal cysteine motif is essential for homo-and heterodimer formation of synaptotagmins III, V, VI, and X. J. Biol. Chem. 274, 31421-31427.
14. Fukuda, M., Saegusa, C. and Mikoshiba, K. (2001). Novel splicing isoforms of synaptotagmin-like proteins 2 and 3: identification of the Slp homology domain. Biochem. Biophys. Res. Commun. 283, 513-519.
15. Gá lvez-Santisteban, M., Rodriguez-Fraticelli, A. E., Bryant, D. M., Vergarajauregui, S., Yasuda, T., Bañón-Rodríguez, I., Bernascone, I., Datta, A., Spivak, N., Young, K. et al. (2012). Synaptotagmin-like proteins control the formation of a single apical membrane domain in epithelial cells. Nat. Cell Biol. 14, 838-849.
16. Gattone, V. H., 2nd, Wang, X., Harris, P. C. and Torres, V. E. (2003). Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat. Med. 9, 1323-1326.
17. Gautreau, A., Poullet, P., Louvard, D. and Arpin, M. (1999). Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 96, 7300-7305.
18. Gloerich, M. and Bos, J. L. (2011). Regulating Rap small G-proteins in time and space. Trends Cell Biol. 21, 615-623.
19. Gloerich, M., ten Klooster, J. P., Vliem, M. J., Koorman, T., Zwartkruis, F. J., Clevers, H. and Bos, J. L. (2012). Rap2A links intestinal cell polarity to brush border formation. Nat. Cell Biol. 14, 793-801.
20. Hatano, R., Fujii, E., Segawa, H., Mukaisho, K., Matsubara, M., Miyamoto, K., Hattori, T., Sugihara, H. and Asano, S. (2013). Ezrin, a membrane cytoskeletal cross-linker, is essential for the regulation of phosphate and calcium homeostasis. Kidney Int. 83, 41-49.
21. Hildebrandt, F., Attanasio, M. and Otto, E. (2009). Nephronophthisis: disease mechanisms of a ciliopathy. J. Am. Soc. Nephrol. 20, 23-35.
22. Holt, O., Kanno, E., Bossi, G., Booth, S., Daniele, T., Santoro, A., Arico, M., Saegusa, C., Fukuda, M. and Griffiths, G. M. (2008). Slp1 and Slp2-a localize to the plasma membrane of CTL and contribute to secretion from the immunological synapse. Traffic 9, 446-457.
23. Hsu, Y. H., Lin, W. L., Hou, Y. T., Pu, Y. S., Shun, C. T., Chen, C. L., Wu, Y. Y., Chen, J. Y., Chen, T. H. and Jou, T. S. (2010). Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am. J. Pathol. 176, 3050-3061.
24. Imai, A., Yoshie, S., Nashida, T., Shimomura, H. and Fukuda, M. (2004). The small GTPase Rab27B regulates amylase release from rat parotid acinar cells. J. Cell Sci. 117, 1945-1953.
25. Kobayashi, H. and Fukuda, M. (2013). Rab35 establishes the EHD1-association site by coordinating two distinct effectors during neurite outgrowth. J. Cell Sci. 126, 2424-2435.
26. Kuroda, T. S. and Fukuda, M. (2004). Rab27A-binding protein Slp2-a is required for peripheral melanosome distribution and elongated cell shape in melanocytes. Nat. Cell Biol. 6, 1195-1203.
27. Kuroda, T. S., Fukuda, M., Ariga, H. and Mikoshiba, K. (2002). The Slp homology domain of synaptotagmin-like proteins 1-4 and Slac2 functions as a novel Rab27A binding domain. J. Biol. Chem. 277, 9212-9218.
28. Li, Y., Konings, I. B. M., Zhao, J., Price, L. S., de Heer, E. and Deen, P. M. T. (2008). Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2. Am. J. Physiol. 295, F525-F533.
29. Lozano, E., Frasa, M. A. M., Smolarczyk, K., Knaus, U. G. and Braga, V. M. M. (2008). PAK is required for the disruption of E-cadherin adhesion by the small GTPase Rac. J. Cell Sci. 121, 933-938.
30. Marciano, D. K., Brakeman, P. R., Lee, C. Z., Spivak, N., Eastburn, D. J., Bryant, D. M., Beaudoin, G. M., 3rd, Hofmann, I., Mostov, K. E. and Reichardt, L. F. (2011). p120 catenin is required for normal renal tubulogenesis and glomerulogenesis. Development 138, 2099-2109.
31. Ménasché , G., Ménager, M. M., Lefebvre, J. M., Deutsch, E., Athman, R., Lambert, N., Mahlaoui, N., Court, M., Garin, J., Fischer, A. et al. (2008). A newly identified isoform of Slp2a associates with Rab27a in cytotoxic Tcells and participates to cytotoxic granule secretion. Blood 112, 5052-5062.
32. Natoli, T. A., Smith, L. A., Rogers, K. A., Wang, B., Komarnitsky, S., Budman, Y., Belenky, A., Bukanov, N. O., Dackowski, W. R., Husson, H. et al. (2010). Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models. Nat. Med. 16, 788-792.
33. Neumüller, O., Hoffmeister, M., Babica, J., Prelle, C., Gegenbauer, K. and Smolenski, A. P. (2009). Synaptotagmin-like protein 1 interacts with the GTPase-activating protein Rap1GAP2 and regulates dense granule secretion in platelets. Blood 114, 1396-1404.
34. Nielsen, S., Frøkiaer, J., Marples, D., Kwon, T. H., Agre, P. and Knepper, M. A. (2002). Aquaporins in the kidney: from molecules to medicine. Physiol. Rev. 82, 205-244.
35. Okada, H., Ban, S., Nagao, S., Takahashi, H., Suzuki, H. and Neilson, E. G. (2000). Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int. 58, 587-597.
36. Olbrich, H., Fliegauf, M., Hoefele, J., Kispert, A., Otto, E., Volz, A., Wolf, M. T., Sasmaz, G., Trauer, U., Reinhardt, R. et al. (2003). Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis. Nat. Genet. 34, 455-459.
37. Omori, S., Hida, M., Fujita, H., Takahashi, H., Tanimura, S., Kohno, M. and Awazu, M. (2006). Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease. J. Am. Soc. Nephrol. 17, 1604-1614.
38. Pilot, F., Philippe, J. M., Lemmers, C. and Lecuit, T. (2006). Spatial control of actin organization at adherens junctions by a synaptotagmin-like protein Btsz. Nature 442, 580-584.
39. Pujuguet, P., Del Maestro, L., Gautreau, A., Louvard, D. and Arpin, M. (2003). Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol. Biol. Cell 14, 2181-2191.
40. Rocco, M. V., Neilson, E. G., Hoyer, J. R. and Ziyadeh, F. N. (1992). Attenuated expression of epithelial cell adhesion molecules in murine polycystic kidney disease. Am. J. Physiol. 262, F679-F686.
41. Ross, S. H., Post, A., Raaijmakers, J. H., Verlaan, I., Gloerich, M. and Bos, J. L. (2011). Ezrin is required for efficient Rap1-induced cell spreading. J. Cell Sci. 124, 1808-1818.
42. Saegusa, C., Tanaka, T., Tani, S., Itohara, S., Mikoshiba, K. and Fukuda, M. (2006). Decreased basal mucus secretion by Slp2-a-deficient gastric surface mucous cells. Genes Cells 11, 623-631.
43. Schultess, J., Danielewski, O. and Smolenski, A. P. (2005). Rap1GAP2 is a new GTPase-activating protein of Rap1 expressed in human platelets. Blood 105, 3185-3192.
44. Serano, J. and Rubin, G. M. (2003). The Drosophila synaptotagmin-like protein bitesize is required for growth and has mRNA localization sequences within its open reading frame. Proc. Natl. Acad. Sci. USA 100, 13368-13373.
45. Shayman, J. A., Deshmukh, G. D., Mahdiyoun, S., Thomas, T. P., Wu, D., Barcelon, F. S. and Radin, N. S. (1991). Modulation of renal epithelial cell growth by glucosylceramide. Association with protein kinase C, sphingosine, and diacylglycerol. J. Biol. Chem. 266, 22968-22974.
46. Tamura, K., Ohbayashi, N., Ishibashi, K. and Fukuda, M. (2011). Structurefunction analysis of VPS9-ankyrin-repeat protein (Varp) in the trafficking of tyrosinase-related protein 1 in melanocytes. J. Biol. Chem. 286, 7507-7521.
47. Torres, V. E. and Harris, P. C. (2006). Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases. Nat. Clin. Pract. Nephrol. 2, 40-55, quiz 55.
48. Torres, V. E. and Harris, P. C. (2009). Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 76, 149-168.
49. Torres, V. E., Chapman, A. B., Devuyst, O., Gansevoort, R. T., Grantham, J. J., Higashihara, E., Perrone, R. D., Krasa, H. B., Ouyang, J., Czerwiec, F. S.; TEMPO 3:4 Trial Investigators (2012). Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 367, 2407-2418.
50. Tsygankova, O. M., Ma, C., Tang,W., Korch, C., Feldman, M. D., Lv, Y., Brose, M. S. andMeinkoth, J. L. (2010). Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Mol. Cell. Biol. 30, 3262-3274.
51. Venier, R. E. and Igdoura, S. A. (2012). Miglustat as a therapeutic agent: prospects and caveats. J. Med. Genet. 49, 591-597.
52. Wilson, P. D. (2004). Polycystic kidney disease. N. Engl. J. Med. 350, 151-164.
53. Wilson, P. D. (2011). Apico-basal polarity in polycystic kidney disease epithelia. Biochim. Biophys. Acta 1812, 1239-1248.
54. Yang, H. S. and Hinds, P. W. (2006). Phosphorylation of ezrin by cyclindependent kinase 5 induces the release of Rho GDP dissociation inhibitor to inhibit Rac1 activity in senescent cells. Cancer Res. 66, 2708-2715.
55. Yasuda, T., Saegusa, C., Kamakura, S., Sumimoto, H. and Fukuda, M. (2012). Rab27 effector Slp2-a transports the apical signaling molecule podocalyxin to the apical surface of MDCK II cells and regulates claudin-2 expression. Mol. Biol. Cell 23, 3229-3239.
56. Zeidan, Y. H., Jenkins, R. W. and Hannun, Y. A. (2008). Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway. J. Cell Biol. 181, 335-350.